{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:49:04Z","timestamp":1787064544137,"version":"build-2736575974"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T00:00:00Z","timestamp":1742428800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T00:00:00Z","timestamp":1742428800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Epigenet"],"DOI":"10.1186\/s13148-025-01845-9","type":"journal-article","created":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T04:39:47Z","timestamp":1742445587000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["DNA methylation heterogeneity correlates with field cancerization and prognosis in lung adenocarcinoma patients"],"prefix":"10.1186","volume":"17","author":[{"given":"Ying","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tengfei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjun","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,20]]},"reference":[{"issue":"3","key":"1845_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"1845_CR2","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1146\/annurev-pathol-042220-022304","volume":"17","author":"A Papanicolau-Sengos","year":"2022","unstructured":"Papanicolau-Sengos A, Aldape K. DNA methylation profiling: an emerging paradigm for cancer diagnosis. Annu Rev Pathol. 2022;17:295\u2013321.","journal-title":"Annu Rev Pathol"},{"issue":"6562","key":"1845_CR3","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1126\/science.abh1645","volume":"373","author":"T Ushijima","year":"2021","unstructured":"Ushijima T, Clark SJ, Tan P. Mapping genomic and epigenomic evolution in cancer ecosystems. Science. 2021;373(6562):1474\u20139.","journal-title":"Science"},{"issue":"8","key":"1845_CR4","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.arcmed.2022.11.003","volume":"53","author":"F Recillas-Targa","year":"2022","unstructured":"Recillas-Targa F. Cancer epigenetics: an overview. Arch Med Res. 2022;53(8):732\u201340.","journal-title":"Arch Med Res"},{"issue":"10","key":"1845_CR5","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1158\/2159-8290.CD-24-0296","volume":"14","author":"M Esteller","year":"2024","unstructured":"Esteller M, Dawson MA, Kadoch C, Rassool FV, Jones PA, Baylin SB. The epigenetic hallmarks of cancer. Cancer Discov. 2024;14(10):1783\u2013809.","journal-title":"Cancer Discov"},{"issue":"1","key":"1845_CR6","doi-asserted-by":"publisher","first-page":"11","DOI":"10.4046\/trd.2012.73.1.11","volume":"73","author":"JU Lee","year":"2012","unstructured":"Lee JU, Sul HJ, Son JW. Promoter methylation of CDKN2A, RARbeta, and RASSF1A in non-small cell lung carcinoma: quantitative evaluation using pyrosequencing. Tuberc Respir Dis (Seoul). 2012;73(1):11\u201321.","journal-title":"Tuberc Respir Dis (Seoul)"},{"issue":"11","key":"1845_CR7","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1097\/JTO.0b013e3182a46c0c","volume":"8","author":"KW Tam","year":"2013","unstructured":"Tam KW, Zhang W, Soh J, Stastny V, Chen M, Sun H, et al. CDKN2A\/p16 inactivation mechanisms and their relationship to smoke exposure and molecular features in non-small-cell lung cancer. J Thorac Oncol. 2013;8(11):1378\u201388.","journal-title":"J Thorac Oncol"},{"key":"1845_CR8","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ebiom.2016.04.017","volume":"8","author":"R Zhao","year":"2016","unstructured":"Zhao R, Choi BY, Lee MH, Bode AM, Dong Z. Implications of genetic and epigenetic alterations of CDKN2A (p16(INK4a)) in cancer. EBioMedicine. 2016;8:30\u20139.","journal-title":"EBioMedicine"},{"issue":"13","key":"1845_CR9","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2018100532","volume":"38","author":"D Pankova","year":"2019","unstructured":"Pankova D, Jiang Y, Chatzifrangkeskou M, Vendrell I, Buzzelli J, Ryan A, et al. RASSF1A controls tissue stiffness and cancer stem-like cells in lung adenocarcinoma. EMBO J. 2019;38(13): e100532.","journal-title":"EMBO J"},{"key":"1845_CR10","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/5584_2015_159","volume":"878","author":"A Dutkowska","year":"2016","unstructured":"Dutkowska A, Antczak A, Pastuszak-Lewandoska D, Migdalska-Sek M, Czarnecka KH, Gorski P, et al. RARbeta promoter methylation as an epigenetic mechanism of gene silencing in non-small cell lung cancer. Adv Exp Med Biol. 2016;878:29\u201338.","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"1845_CR11","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1038\/s41598-018-19949-z","volume":"8","author":"L Chen","year":"2018","unstructured":"Chen L, Wang Y, Liu F, Xu L, Peng F, Zhao N, et al. A systematic review and meta-analysis: association between MGMT hypermethylation and the clinicopathological characteristics of non-small-cell lung carcinoma. Sci Rep. 2018;8(1):1439.","journal-title":"Sci Rep"},{"issue":"1","key":"1845_CR12","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1073\/pnas.0710735105","volume":"105","author":"TA Rauch","year":"2008","unstructured":"Rauch TA, Zhong X, Wu X, Wang M, Kernstine KH, Wang Z, et al. High-resolution mapping of DNA hypermethylation and hypomethylation in lung cancer. Proc Natl Acad Sci U S A. 2008;105(1):252\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"1845_CR13","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1093\/carcin\/bgs363","volume":"34","author":"G Heller","year":"2013","unstructured":"Heller G, Babinsky VN, Ziegler B, Weinzierl M, Noll C, Altenberger C, et al. Genome-wide CpG island methylation analyses in non-small cell lung cancer patients. Carcinogenesis. 2013;34(3):513\u201321.","journal-title":"Carcinogenesis"},{"issue":"6","key":"1845_CR14","doi-asserted-by":"publisher","first-page":"e401","DOI":"10.1002\/mco2.401","volume":"4","author":"S Ramazi","year":"2023","unstructured":"Ramazi S, Daddzadi M, Sahafnejad Z, Allahverdi A. Epigenetic regulation in lung cancer. MedComm (2020). 2023;4(6):e401.","journal-title":"MedComm (2020)"},{"issue":"1","key":"1845_CR15","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/nrc.2017.102","volume":"18","author":"K Curtius","year":"2018","unstructured":"Curtius K, Wright NA, Graham TA. An evolutionary perspective on field cancerization. Nat Rev Cancer. 2018;18(1):19\u201332.","journal-title":"Nat Rev Cancer"},{"key":"1845_CR16","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1146\/annurev.pathol.1.110304.100103","volume":"1","author":"II Wistuba","year":"2006","unstructured":"Wistuba II, Gazdar AF. Lung cancer preneoplasia. Annu Rev Pathol. 2006;1:331\u201348.","journal-title":"Annu Rev Pathol"},{"issue":"3","key":"1845_CR17","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1158\/1940-6207.CAPR-08-0032","volume":"1","author":"X Tang","year":"2008","unstructured":"Tang X, Varella-Garcia M, Xavier AC, Massarelli E, Ozburn N, Moran C, et al. Epidermal growth factor receptor abnormalities in the pathogenesis and progression of lung adenocarcinomas. Cancer Prev Res (Phila). 2008;1(3):192\u2013200.","journal-title":"Cancer Prev Res (Phila)"},{"issue":"2","key":"1845_CR18","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1513\/pats.201201-004MS","volume":"9","author":"H Kadara","year":"2012","unstructured":"Kadara H, Wistuba II. Field cancerization in non-small cell lung cancer: implications in disease pathogenesis. Proc Am Thorac Soc. 2012;9(2):38\u201342.","journal-title":"Proc Am Thorac Soc"},{"issue":"1\u20132","key":"1845_CR19","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1155\/2007\/985474","volume":"23","author":"KM Kerr","year":"2007","unstructured":"Kerr KM, Galler JS, Hagen JA, Laird PW, Laird-Offringa IA. The role of DNA methylation in the development and progression of lung adenocarcinoma. Dis Markers. 2007;23(1\u20132):5\u201330.","journal-title":"Dis Markers"},{"issue":"17","key":"1845_CR20","doi-asserted-by":"publisher","first-page":"7635","DOI":"10.7150\/thno.44229","volume":"10","author":"L Yang","year":"2020","unstructured":"Yang L, Zhang J, Yang G, Xu H, Lin J, Shao L, et al. The prognostic value of a methylome-based malignancy density scoring system to predict recurrence risk in early-stage lung adenocarcinoma. Theranostics. 2020;10(17):7635\u201344.","journal-title":"Theranostics"},{"issue":"1","key":"1845_CR21","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13148-020-00985-4","volume":"13","author":"J Sui","year":"2021","unstructured":"Sui J, Wu X, Wang C, Wang G, Li C, Zhao J, et al. Discovery and validation of methylation signatures in blood-based circulating tumor cell-free DNA in early detection of colorectal carcinoma: a case-control study. Clin Epigenetics. 2021;13(1):26.","journal-title":"Clin Epigenetics"},{"issue":"4","key":"1845_CR22","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1093\/annonc\/mdy009","volume":"29","author":"YS Li","year":"2018","unstructured":"Li YS, Jiang BY, Yang JJ, Zhang XC, Zhang Z, Ye JY, et al. Unique genetic profiles from cerebrospinal fluid cell-free DNA in leptomeningeal metastases of EGFR-mutant non-small-cell lung cancer: a new medium of liquid biopsy. Ann Oncol. 2018;29(4):945\u201352.","journal-title":"Ann Oncol"},{"issue":"12","key":"1845_CR23","doi-asserted-by":"publisher","first-page":"3513","DOI":"10.1007\/s00262-021-02943-2","volume":"70","author":"X Chen","year":"2021","unstructured":"Chen X, Fang L, Zhu Y, Bao Z, Wang Q, Liu R, et al. Blood tumor mutation burden can predict the clinical response to immune checkpoint inhibitors in advanced non-small cell lung cancer patients. Cancer Immunol Immunother. 2021;70(12):3513\u201324.","journal-title":"Cancer Immunol Immunother"},{"issue":"6","key":"1845_CR24","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41551-021-00746-5","volume":"5","author":"N Liang","year":"2021","unstructured":"Liang N, Li B, Jia Z, Wang C, Wu P, Zheng T, et al. Ultrasensitive detection of circulating tumour DNA via deep methylation sequencing aided by machine learning. Nat Biomed Eng. 2021;5(6):586\u201399.","journal-title":"Nat Biomed Eng"},{"issue":"17","key":"1845_CR25","doi-asserted-by":"publisher","first-page":"3824","DOI":"10.1158\/1078-0432.CCR-22-0391","volume":"28","author":"K Guidry","year":"2022","unstructured":"Guidry K, Vasudevaraja V, Labbe K, Mohamed H, Serrano J, Guidry BW, et al. DNA methylation profiling identifies subgroups of lung adenocarcinoma with distinct immune cell composition, DNA methylation age, and clinical outcome. Clin Cancer Res. 2022;28(17):3824\u201335.","journal-title":"Clin Cancer Res"},{"issue":"10","key":"1845_CR26","doi-asserted-by":"publisher","first-page":"R115","DOI":"10.1186\/gb-2013-14-10-r115","volume":"14","author":"S Horvath","year":"2013","unstructured":"Horvath S. DNA methylation age of human tissues and cell types. Genome Biol. 2013;14(10):R115.","journal-title":"Genome Biol"},{"issue":"11","key":"1845_CR27","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1056\/NEJMra072067","volume":"358","author":"M Esteller","year":"2008","unstructured":"Esteller M. Epigenetics in cancer. N Engl J Med. 2008;358(11):1148\u201359.","journal-title":"N Engl J Med"},{"issue":"9","key":"1845_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0044951","volume":"7","author":"M Brait","year":"2012","unstructured":"Brait M, Ling S, Nagpal JK, Chang X, Park HL, Lee J, et al. Cysteine dioxygenase 1 is a tumor suppressor gene silenced by promoter methylation in multiple human cancers. PLoS ONE. 2012;7(9): e44951.","journal-title":"PLoS ONE"},{"key":"1845_CR29","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.jss.2020.07.001","volume":"256","author":"H Harada","year":"2020","unstructured":"Harada H, Soeno T, Yokoi K, Nishizawa N, Ushiku H, Hosoda K, et al. Prediction of efficacy of postoperative chemotherapy by DNA methylation of CDO1 in gastric cancer. J Surg Res. 2020;256:404\u201312.","journal-title":"J Surg Res"},{"issue":"2","key":"1845_CR30","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1245\/s10434-018-6865-z","volume":"26","author":"K Yokoi","year":"2019","unstructured":"Yokoi K, Harada H, Yokota K, Ishii S, Tanaka T, Nishizawa N, et al. Epigenetic status of CDO1 gene may reflect chemosensitivity in colon cancer with postoperative adjuvant chemotherapy. Ann Surg Oncol. 2019;26(2):406\u201314.","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"1845_CR31","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.21873\/anticanres.13345","volume":"39","author":"Y Tanaka","year":"2019","unstructured":"Tanaka Y, Kosaka Y, Waraya M, Yokota K, Harada H, Kaida T, et al. Differential prognostic relevance of promoter DNA methylation of CDO1 and HOPX in primary breast cancer. Anticancer Res. 2019;39(5):2289\u201398.","journal-title":"Anticancer Res"},{"issue":"9","key":"1845_CR32","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1111\/cas.14134","volume":"110","author":"N Nishizawa","year":"2019","unstructured":"Nishizawa N, Harada H, Kumamoto Y, Kaizu T, Katoh H, Tajima H, et al. Diagnostic potential of hypermethylation of the cysteine dioxygenase 1 gene (CDO1) promoter DNA in pancreatic cancer. Cancer Sci. 2019;110(9):2846\u201355.","journal-title":"Cancer Sci"},{"issue":"10","key":"1845_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0205864","volume":"13","author":"S Nakamoto","year":"2018","unstructured":"Nakamoto S, Kumamoto Y, Igarashi K, Fujiyama Y, Nishizawa N, Ei S, et al. Methylated promoter DNA of CDO1 gene and preoperative serum CA19-9 are prognostic biomarkers in primary extrahepatic cholangiocarcinoma. PLoS ONE. 2018;13(10): e0205864.","journal-title":"PLoS ONE"},{"issue":"16","key":"1845_CR34","doi-asserted-by":"publisher","first-page":"4339","DOI":"10.1158\/1078-0432.CCR-19-2896","volume":"26","author":"B Liu","year":"2020","unstructured":"Liu B, Ricarte Filho J, Mallisetty A, Villani C, Kottorou A, Rodgers K, et al. Detection of promoter DNA methylation in urine and plasma aids the detection of non-small cell lung cancer. Clin Cancer Res. 2020;26(16):4339\u201348.","journal-title":"Clin Cancer Res"},{"issue":"7","key":"1845_CR35","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1158\/1078-0432.CCR-13-2109","volume":"20","author":"J Wrangle","year":"2014","unstructured":"Wrangle J, Machida EO, Danilova L, Hulbert A, Franco N, Zhang W, et al. Functional identification of cancer-specific methylation of CDO1, HOXA9, and TAC1 for the diagnosis of lung cancer. Clin Cancer Res. 2014;20(7):1856\u201364.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"1845_CR36","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1097\/JTO.0b013e3182307f62","volume":"7","author":"YJ Kwon","year":"2012","unstructured":"Kwon YJ, Lee SJ, Koh JS, Kim SH, Lee HW, Kang MC, et al. Genome-wide analysis of DNA methylation and the gene expression change in lung cancer. J Thorac Oncol. 2012;7(1):20\u201333.","journal-title":"J Thorac Oncol"},{"key":"1845_CR37","doi-asserted-by":"crossref","unstructured":"Kang YP, Torrente L, Falzone A, Elkins CM, Liu M, Asara JM, et al. Cysteine dioxygenase 1 is a metabolic liability for non-small cell lung cancer. Elife. 2019;8.","DOI":"10.7554\/eLife.45572"},{"issue":"1","key":"1845_CR38","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3892\/or.2015.3993","volume":"34","author":"T Kok-Sin","year":"2015","unstructured":"Kok-Sin T, Mokhtar NM, Ali Hassan NZ, Sagap I, Mohamed Rose I, Harun R, et al. Identification of diagnostic markers in colorectal cancer via integrative epigenomics and genomics data. Oncol Rep. 2015;34(1):22\u201332.","journal-title":"Oncol Rep"},{"issue":"1","key":"1845_CR39","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s13277-015-3792-5","volume":"37","author":"X Lu","year":"2016","unstructured":"Lu X, Wan F, Zhang H, Shi G, Ye D. ITGA2B and ITGA8 are predictive of prognosis in clear cell renal cell carcinoma patients. Tumour Biol. 2016;37(1):253\u201362.","journal-title":"Tumour Biol"},{"key":"1845_CR40","doi-asserted-by":"publisher","first-page":"1096818","DOI":"10.3389\/fimmu.2023.1096818","volume":"14","author":"X Li","year":"2023","unstructured":"Li X, Zhu G, Li Y, Huang H, Chen C, Wu D, et al. LINC01798\/miR-17-5p axis regulates ITGA8 and causes changes in tumor microenvironment and stemness in lung adenocarcinoma. Front Immunol. 2023;14:1096818.","journal-title":"Front Immunol"},{"issue":"24","key":"1845_CR41","doi-asserted-by":"publisher","first-page":"25275","DOI":"10.18632\/aging.104129","volume":"12","author":"F Xu","year":"2020","unstructured":"Xu F, He L, Zhan X, Chen J, Xu H, Huang X, et al. DNA methylation-based lung adenocarcinoma subtypes can predict prognosis, recurrence, and immunotherapeutic implications. Aging (Albany NY). 2020;12(24):25275\u201393.","journal-title":"Aging (Albany NY)"},{"issue":"4","key":"1845_CR42","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.21037\/jtd-23-494","volume":"15","author":"R Yu","year":"2023","unstructured":"Yu R, Huang X, Lin J, Lin S, Shen G, Chen W. Bioinformatics analysis based on DNA methylation data identified in lung adenocarcinoma subgroups with different immune characteristics and clinical outcomes. J Thorac Dis. 2023;15(4):2184\u201397.","journal-title":"J Thorac Dis"},{"issue":"1","key":"1845_CR43","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s12885-021-07846-0","volume":"21","author":"K Yang","year":"2021","unstructured":"Yang K, Wu Y. A prognosis-related molecular subtype for early-stage non-small lung cell carcinoma by multi-omics integration analysis. BMC Cancer. 2021;21(1):128.","journal-title":"BMC Cancer"},{"issue":"1","key":"1845_CR44","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s12885-021-07888-4","volume":"21","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, Gao Y, Xu X, Zhou J, Wang H. Multi-omics analysis of genomics, epigenomics and transcriptomics for molecular subtypes and core genes for lung adenocarcinoma. BMC Cancer. 2021;21(1):257.","journal-title":"BMC Cancer"},{"key":"1845_CR45","doi-asserted-by":"crossref","unstructured":"Patergnani S, Danese A, Bouhamida E, Aguiari G, Previati M, Pinton P, et al. Various aspects of calcium signaling in the regulation of apoptosis, autophagy, cell proliferation, and cancer. Int J Mol Sci. 2020;21(21).","DOI":"10.3390\/ijms21218323"},{"issue":"21","key":"1845_CR46","doi-asserted-by":"publisher","first-page":"6187","DOI":"10.1111\/febs.16133","volume":"288","author":"L Wu","year":"2021","unstructured":"Wu L, Lian W, Zhao L. Calcium signaling in cancer progression and therapy. FEBS J. 2021;288(21):6187\u2013205.","journal-title":"FEBS J"},{"issue":"8","key":"1845_CR47","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/nrc3105","volume":"11","author":"N Prevarskaya","year":"2011","unstructured":"Prevarskaya N, Skryma R, Shuba Y. Calcium in tumour metastasis: new roles for known actors. Nat Rev Cancer. 2011;11(8):609\u201318.","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"1845_CR48","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.21037\/tcr-21-2395","volume":"11","author":"Y Wang","year":"2022","unstructured":"Wang Y, Chen Y, Zhang L, Xiong J, Xu L, Cheng C, et al. Ryanodine receptor (RYR) mutational status correlates with tumor mutational burden, age and smoking status and stratifies non-small cell lung cancer patient prognosis. Transl Cancer Res. 2022;11(7):2070\u201383.","journal-title":"Transl Cancer Res"},{"key":"1845_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2023.147690","volume":"885","author":"A Valter","year":"2023","unstructured":"Valter A, Luhari L, Pisarev H, Truumees B, Planken A, Smolander OP, et al. Genomic alterations as independent prognostic factors to predict the type of lung cancer recurrence. Gene. 2023;885: 147690.","journal-title":"Gene"},{"issue":"1","key":"1845_CR50","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/ng.500","volume":"42","author":"DB Hancock","year":"2010","unstructured":"Hancock DB, Eijgelsheim M, Wilk JB, Gharib SA, Loehr LR, Marciante KD, et al. Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function. Nat Genet. 2010;42(1):45\u201352.","journal-title":"Nat Genet"},{"issue":"6","key":"1845_CR51","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1001\/archpsyc.65.6.683","volume":"65","author":"GR Uhl","year":"2008","unstructured":"Uhl GR, Liu QR, Drgon T, Johnson C, Walther D, Rose JE, et al. Molecular genetics of successful smoking cessation: convergent genome-wide association study results. Arch Gen Psychiatry. 2008;65(6):683\u201393.","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"1845_CR52","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3892\/ijo.2013.2150","volume":"44","author":"LT Fang","year":"2014","unstructured":"Fang LT, Lee S, Choi H, Kim HK, Jew G, Kang HC, et al. Comprehensive genomic analyses of a metastatic colon cancer to the lung by whole exome sequencing and gene expression analysis. Int J Oncol. 2014;44(1):211\u201321.","journal-title":"Int J Oncol"},{"issue":"15","key":"1845_CR53","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.3748\/wjg.v17.i15.2028","volume":"17","author":"SJ Yu","year":"2011","unstructured":"Yu SJ, Yu JK, Ge WT, Hu HG, Yuan Y, Zheng S. SPARCL1, Shp2, MSH2, E-cadherin, p53, ADCY-2 and MAPK are prognosis-related in colorectal cancer. World J Gastroenterol. 2011;17(15):2028\u201336.","journal-title":"World J Gastroenterol"},{"issue":"7","key":"1845_CR54","doi-asserted-by":"publisher","first-page":"11868","DOI":"10.18632\/oncotarget.14417","volume":"8","author":"XX Wang","year":"2017","unstructured":"Wang XX, Xiao FH, Li QG, Liu J, He YH, Kong QP. Large-scale DNA methylation expression analysis across 12 solid cancers reveals hypermethylation in the calcium-signaling pathway. Oncotarget. 2017;8(7):11868\u201376.","journal-title":"Oncotarget"},{"key":"1845_CR55","doi-asserted-by":"crossref","unstructured":"Zhang C, Zhao H, Cai Y, Xiong J, Mohan A, Lou D, et al. Cyclic nucleotide phosphodiesterase 1C contributes to abdominal aortic aneurysm. Proc Natl Acad Sci U S A. 2021;118(31).","DOI":"10.1073\/pnas.2107898118"},{"issue":"3","key":"1845_CR56","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1002\/mc.22276","volume":"55","author":"FB Rowther","year":"2016","unstructured":"Rowther FB, Wei W, Dawson TP, Ashton K, Singh A, Madiesse-Timchou MP, et al. Cyclic nucleotide phosphodiesterase-1C (PDE1C) drives cell proliferation, migration and invasion in glioblastoma multiforme cells in vitro. Mol Carcinog. 2016;55(3):268\u201379.","journal-title":"Mol Carcinog"},{"issue":"4","key":"1845_CR57","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1080\/1354750X.2018.1427795","volume":"23","author":"A Bouzid","year":"2018","unstructured":"Bouzid A, Smeti I, Dhouib L, Roche M, Achour I, Khalfallah A, et al. Down-expression of P2RX2, KCNQ5, ERBB3 and SOCS3 through DNA hypermethylation in elderly women with presbycusis. Biomarkers. 2018;23(4):347\u201356.","journal-title":"Biomarkers"},{"key":"1845_CR58","doi-asserted-by":"publisher","first-page":"8058160","DOI":"10.1155\/2022\/8058160","volume":"2022","author":"Q Li","year":"2022","unstructured":"Li Q, Wu B, Daba M, Gao X, Chen B, Song G, et al. Identification of calcium channel-related gene P2RX2 for prognosis and immune infiltration in prostate cancer. Dis Markers. 2022;2022:8058160.","journal-title":"Dis Markers"}],"container-title":["Clinical Epigenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-025-01845-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13148-025-01845-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-025-01845-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T15:09:13Z","timestamp":1742483353000},"score":1,"resource":{"primary":{"URL":"https:\/\/clinicalepigeneticsjournal.biomedcentral.com\/articles\/10.1186\/s13148-025-01845-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,20]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1845"],"URL":"https:\/\/doi.org\/10.1186\/s13148-025-01845-9","relation":{},"ISSN":["1868-7083"],"issn-type":[{"value":"1868-7083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,20]]},"assertion":[{"value":"13 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of Tianjin Cancer Hospital. Informed consent was obtained from all patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent for publication was obtained from all patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"BL and TZ are employees of Burning Rock Biotech, Guangzhou, China. Other authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"50"}}